A new clinical trial (June 2025) investigates ATR‑04, a microbiome-based topical therapy using engineered Staphylococcus epidermidis to treat EGFR inhibitor–related...
Read moreDetails
A groundbreaking May 2025 study published in Nature Communications challenges the long-standing belief of a sterile brain: microbial traces identified...
Read moreDetails
EGFR and Lysosomes: Cell Biology Rewritten by a Single Receptor An April 2025 study unveils a novel role for the...
Read moreDetailsThe Patent ® Newspaper registered at the court of Salerno with n.42019. Editor-in-Chief Giovanni Sapere | Copyright 2019 © Creatiwa Studio S.r.l. Publisher | All rights reserved | For advertising: Creatiwa Studio Sr.l. Head office Via privata del Gonfalone 3, 20123 Milan | Registered office: Via Scavate Casse Rosse snc – 84131 Salerno | Tax code, VAT no. 05675660657 Registration with the Register of Companies of Salerno REA SA – 465001
2017 – 2025 The Patent ™ Director Giovanni Sapere
